Ferrari have brought in their second new driver for the 2025 season, naming Zhou Guanyu in a reserve role. The Chinese driver ...

Guanyu Zhou admits he “lost hope” for his future in Formula 1 with the Audi-owned Sauber team last year. The sport’s ...

Zhou Guanyu confirmed as Ferrari driver for 2025 F1 season - Ferrari have added to their ranks ahead of Lewis Hamilton’s ...

MARANELLO, Italy (AP) — The first Chinese driver in Formula 1, Zhou Guanyu, is heading back to Ferrari as one of its reserve drivers for the 2025 season. Zhou doesn't have a race seat for 2025 after ...

The latest car news, videos and expert reviews, from Cars.com's independent automotive journalists Read our region-by-region breakdown of the Trump administration’s tariff proposals and ...

Ferrari has confirmed that former Sauber charger Zhou Guanyu will take on a reserve role with the Scuderia this season.

This year, China Media Group’s (CMG) annual Spring Festival Gala variety show, celebrating the advent of the Year of the Snake, featured the usual line-up of song and dance routines, operatic ...

This protocol describes an ex vivo feeder-free culture method to differentiate genetically engineered hematopoietic stem and progenitor cells into allogeneic CAR-NKT cells for off-the-shelf cancer ...

Autoblog brings you car news; expert reviews of cars, trucks, crossovers and SUVs; and pictures and video. Research and compare vehicles, find local dealers, calculate loan payments, find your car ...

Yu Yunique 2 mobile was launched in July 2017. The phone comes with a 5.00-inch touchscreen display offering a resolution of 720x1280 pixels. Yu Yunique 2 is powered by a 1.3GHz quad-core MediaTek ...

Tumor immunotherapies, including immune check point inhibitors, chimeric antigen receptor T cells (CAR-T) and bispecific antibodies (BsAb), have shown significant potential. It is known that the ...

Placental site trophoblastic tumor (PSTT) is a rare type of gestational trophoblastic disease originating from the intermediate trophoblast. Compared with hydatidiform mole, invasive hydatidiform mole ...